Antineoplastic Combined Chemotherapy Protocols
"Antineoplastic Combined Chemotherapy Protocols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
| Descriptor ID |
D000971
|
| MeSH Number(s) |
E02.183.750.500 E02.319.077.500 E02.319.310.037
|
| Concept/Terms |
Antineoplastic Combined Chemotherapy Protocols- Antineoplastic Combined Chemotherapy Protocols
- Combined Antineoplastic Agents
- Antineoplastic Agents, Combined
- Agent, Combined Antineoplastic
- Agents, Combined Antineoplastic
- Antineoplastic Agent, Combined
- Combined Antineoplastic Agent
- Antineoplastic Combined Chemotherapy Regimens
- Drug Combinations, Antineoplastic
- Anticancer Drug Combinations
- Anticancer Drug Combination
- Drug Combination, Anticancer
- Drug Combinations, Anticancer
- Antineoplastic Drug Combinations
- Antineoplastic Drug Combination
- Combinations, Antineoplastic Drug
- Drug Combination, Antineoplastic
Antineoplastic Chemotherapy Protocols- Antineoplastic Chemotherapy Protocols
- Antineoplastic Chemotherapy Protocol
- Chemotherapy Protocol, Antineoplastic
- Protocol, Antineoplastic Chemotherapy
- Protocols, Antineoplastic Chemotherapy
- Cancer Chemotherapy Protocols
- Cancer Chemotherapy Protocol
- Chemotherapy Protocol, Cancer
- Chemotherapy Protocols, Cancer
- Protocol, Cancer Chemotherapy
- Protocols, Cancer Chemotherapy
- Chemotherapy Protocols, Antineoplastic
|
Below are MeSH descriptors whose meaning is more general than "Antineoplastic Combined Chemotherapy Protocols".
Below are MeSH descriptors whose meaning is more specific than "Antineoplastic Combined Chemotherapy Protocols".
This graph shows the total number of publications written about "Antineoplastic Combined Chemotherapy Protocols" by people in this website by year, and whether "Antineoplastic Combined Chemotherapy Protocols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 6 | 2 | 8 |
| 1997 | 7 | 1 | 8 |
| 1998 | 10 | 2 | 12 |
| 1999 | 7 | 0 | 7 |
| 2000 | 8 | 3 | 11 |
| 2001 | 4 | 3 | 7 |
| 2002 | 6 | 7 | 13 |
| 2003 | 8 | 7 | 15 |
| 2004 | 6 | 5 | 11 |
| 2005 | 13 | 5 | 18 |
| 2006 | 11 | 4 | 15 |
| 2007 | 10 | 4 | 14 |
| 2008 | 23 | 8 | 31 |
| 2009 | 21 | 9 | 30 |
| 2010 | 19 | 12 | 31 |
| 2011 | 20 | 15 | 35 |
| 2012 | 20 | 5 | 25 |
| 2013 | 21 | 6 | 27 |
| 2014 | 32 | 12 | 44 |
| 2015 | 28 | 11 | 39 |
| 2016 | 12 | 21 | 33 |
| 2017 | 28 | 18 | 46 |
| 2018 | 41 | 16 | 57 |
| 2019 | 43 | 15 | 58 |
| 2020 | 28 | 24 | 52 |
| 2021 | 15 | 36 | 51 |
| 2022 | 8 | 40 | 48 |
| 2023 | 6 | 42 | 48 |
| 2024 | 27 | 24 | 51 |
| 2025 | 40 | 7 | 47 |
| 2026 | 22 | 6 | 28 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antineoplastic Combined Chemotherapy Protocols" by people in Profiles.
-
Real-world efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in HR+/HER2?-?metastatic breast cancer: a single-institution experience. J Egypt Natl Canc Inst. 2026 Jul 28; 38(1).
-
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis. ESMO Open. 2026 Jul; 11(7):108248.
-
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study. JCO Precis Oncol. 2026 Jun; 10(6):e2501285.
-
Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes. Blood Adv. 2026 Jun 23; 10(12):4184-4192.
-
Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort. Leuk Res. 2026 Aug; 167:108265.
-
Growing teratoma syndrome of the ovary: a case series. J Med Case Rep. 2026 May 24; 20(1).
-
Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and Management. Am J Hematol. 2026 Aug; 101(8):1997-2006.
-
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases. J Immunother Cancer. 2026 May 04; 14(5).
-
Malignant peripheral nerve sheath tumors: a report from Children's Oncology Group study ARST0332. J Natl Cancer Inst. 2026 May 01; 118(5):829-838.
-
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia. Hematol Oncol. 2026 May; 44(3):e70198.